Nenggang Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nenggang Zhang has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Debananda Pati
Baylor College of Medicine 1 Texas Children’s Cancer Center, Department of Pediatrics, Molecular and Cellular Biology, Dan L. Duncan Cancer Center Houston, Texas
17 shared publications - Gaye N. Jenkins
Baylor College of Medicine 1 Texas Children’s Cancer Center, Department of Pediatrics, Molecular and Cellular Biology, Dan L. Duncan Cancer Center Houston, Texas
12 shared publications - Mary Perez
Baylor College of Medicine 1 Texas Children’s Cancer Center, Department of Pediatrics, Molecular and Cellular Biology, Dan L. Duncan Cancer Center Houston, Texas
12 shared publications - Scott Richard Gilbertson
Department of Chemistry, University of Houston, Houston TX 77204, USA
12 shared publications - Terzah M. Horton
Baylor College of Medicine; Texas Children's Hospital, Houston, Texas, United States
12 shared publications Alexis Quezada
Baylor College of Medicine, Department of Molecular and Cellular Biology, Houston, Texas
1 shared publication
Latest Publications
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Figure S1 from Unfolded Protein Response as a Therapeutic Target: 4-(Heptyloxy)phenol Induces Programmed Cell Death in Ewing Sarcoma
Figure S1 from Unfolded Protein Response as a Therapeutic Target: 4-(Heptyloxy)phenol Induces Programmed Cell Death in Ewing Sarcoma
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Unfolded Protein Response as a Therapeutic Target: 4-(Heptyloxy)phenol Induces Programmed Cell Death in Ewing Sarcoma
Figure S1 from Unfolded Protein Response as a Therapeutic Target: 4-(Heptyloxy)phenol Induces Programmed Cell Death in Ewing Sarcoma
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Figure S8 from Unfolded Protein Response as a Therapeutic Target: 4-(Heptyloxy)phenol Induces Programmed Cell Death in Ewing Sarcoma
Figure S8 from Unfolded Protein Response as a Therapeutic Target: 4-(Heptyloxy)phenol Induces Programmed Cell Death in Ewing Sarcoma
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S8 from Unfolded Protein Response as a Therapeutic Target: 4-(Heptyloxy)phenol Induces Programmed Cell Death in Ewing Sarcoma
Figure S8 from Unfolded Protein Response as a Therapeutic Target: 4-(Heptyloxy)phenol Induces Programmed Cell Death in Ewing Sarcoma
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Figure S2 from Unfolded Protein Response as a Therapeutic Target: 4-(Heptyloxy)phenol Induces Programmed Cell Death in Ewing Sarcoma
Figure S2 from Unfolded Protein Response as a Therapeutic Target: 4-(Heptyloxy)phenol Induces Programmed Cell Death in Ewing Sarcoma
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from Unfolded Protein Response as a Therapeutic Target: 4-(Heptyloxy)phenol Induces Programmed Cell Death in Ewing Sarcoma
Figure S2 from Unfolded Protein Response as a Therapeutic Target: 4-(Heptyloxy)phenol Induces Programmed Cell Death in Ewing Sarcoma
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Figure S4 from Unfolded Protein Response as a Therapeutic Target: 4-(Heptyloxy)phenol Induces Programmed Cell Death in Ewing Sarcoma
Figure S4 from Unfolded Protein Response as a Therapeutic Target: 4-(Heptyloxy)phenol Induces Programmed Cell Death in Ewing Sarcoma
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from Unfolded Protein Response as a Therapeutic Target: 4-(Heptyloxy)phenol Induces Programmed Cell Death in Ewing Sarcoma
Figure S4 from Unfolded Protein Response as a Therapeutic Target: 4-(Heptyloxy)phenol Induces Programmed Cell Death in Ewing Sarcoma
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Data from Unfolded Protein Response as a Therapeutic Target: 4-(Heptyloxy)phenol Induces Programmed Cell Death in Ewing Sarcoma
Ewing sarcoma is a rare and aggressive pediatric malignancy with limited therapeutic options, particularly for relapsed or refractory cases, highlighting the urgent need for innovative treatment strategies. In this study, we identify endoplasmic reticulum stress (ERS) and the unfolded protein response (UPR) as critical therapeutic vulnerabilities in Ewing sarcoma and introduce 4-(heptyloxy)phenol (AC-45594) as a novel small-molecule agent that exploits these stress pathways. AC-45594 selectively inhibited the growth of Ewing sarcoma cells among 13 cancer and 6 noncancerous cell lines, demonstrating marked tumor specificity. Structure–activity relationship studies revealed that both the phenolic hydroxyl group and an optimal alkoxy chain length (7–9 carbon atoms) are essential for its activity. Mechanistically, AC-45594 induces ERS, activates UPR, and drives a shift from adaptive to terminal stress signaling, culminating in apoptosis of Ewing sarcoma cells. Proteomic and gene expression analyses further supported the selective activation of proapoptotic UPR signaling. These findings establish ERS and UPR as actionable targets in Ewing sarcoma and position AC-45594 as a first-in-class compound capable of selectively inducing stress-driven cell death. This work lays the foundation for a new class of therapeutics targeting maladaptive stress responses in pediatric sarcomas and potentially other hard-to-treat cancers.
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessData from Unfolded Protein Response as a Therapeutic Target: 4-(Heptyloxy)phenol Induces Programmed Cell Death in Ewing Sarcoma
Ewing sarcoma is a rare and aggressive pediatric malignancy with limited therapeutic options, particularly for relapsed or refractory cases, highlighting the urgent need for innovative treatment strategies. In this study, we identify endoplasmic reticulum stress (ERS) and the unfolded protein response (UPR) as critical therapeutic vulnerabilities in Ewing sarcoma and introduce 4-(heptyloxy)phenol (AC-45594) as a novel small-molecule agent that exploits these stress pathways. AC-45594 selectively inhibited the growth of Ewing sarcoma cells among 13 cancer and 6 noncancerous cell lines, demonstrating marked tumor specificity. Structure–activity relationship studies revealed that both the phenolic hydroxyl group and an optimal alkoxy chain length (7–9 carbon atoms) are essential for its activity. Mechanistically, AC-45594 induces ERS, activates UPR, and drives a shift from adaptive to terminal stress signaling, culminating in apoptosis of Ewing sarcoma cells. Proteomic and gene expression analyses further supported the selective activation of proapoptotic UPR signaling. These findings establish ERS and UPR as actionable targets in Ewing sarcoma and position AC-45594 as a first-in-class compound capable of selectively inducing stress-driven cell death. This work lays the foundation for a new class of therapeutics targeting maladaptive stress responses in pediatric sarcomas and potentially other hard-to-treat cancers.
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Figure S3 from Unfolded Protein Response as a Therapeutic Target: 4-(Heptyloxy)phenol Induces Programmed Cell Death in Ewing Sarcoma
Figure S3 from Unfolded Protein Response as a Therapeutic Target: 4-(Heptyloxy)phenol Induces Programmed Cell Death in Ewing Sarcoma
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Unfolded Protein Response as a Therapeutic Target: 4-(Heptyloxy)phenol Induces Programmed Cell Death in Ewing Sarcoma
Figure S3 from Unfolded Protein Response as a Therapeutic Target: 4-(Heptyloxy)phenol Induces Programmed Cell Death in Ewing Sarcoma
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Figure S9 from Unfolded Protein Response as a Therapeutic Target: 4-(Heptyloxy)phenol Induces Programmed Cell Death in Ewing Sarcoma
Figure S9 from Unfolded Protein Response as a Therapeutic Target: 4-(Heptyloxy)phenol Induces Programmed Cell Death in Ewing Sarcoma
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S9 from Unfolded Protein Response as a Therapeutic Target: 4-(Heptyloxy)phenol Induces Programmed Cell Death in Ewing Sarcoma
Figure S9 from Unfolded Protein Response as a Therapeutic Target: 4-(Heptyloxy)phenol Induces Programmed Cell Death in Ewing Sarcoma
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Figure S6 from Unfolded Protein Response as a Therapeutic Target: 4-(Heptyloxy)phenol Induces Programmed Cell Death in Ewing Sarcoma
Figure S6 from Unfolded Protein Response as a Therapeutic Target: 4-(Heptyloxy)phenol Induces Programmed Cell Death in Ewing Sarcoma
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from Unfolded Protein Response as a Therapeutic Target: 4-(Heptyloxy)phenol Induces Programmed Cell Death in Ewing Sarcoma
Figure S6 from Unfolded Protein Response as a Therapeutic Target: 4-(Heptyloxy)phenol Induces Programmed Cell Death in Ewing Sarcoma
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Figure S5 from Unfolded Protein Response as a Therapeutic Target: 4-(Heptyloxy)phenol Induces Programmed Cell Death in Ewing Sarcoma
Figure S5 from Unfolded Protein Response as a Therapeutic Target: 4-(Heptyloxy)phenol Induces Programmed Cell Death in Ewing Sarcoma
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from Unfolded Protein Response as a Therapeutic Target: 4-(Heptyloxy)phenol Induces Programmed Cell Death in Ewing Sarcoma
Figure S5 from Unfolded Protein Response as a Therapeutic Target: 4-(Heptyloxy)phenol Induces Programmed Cell Death in Ewing Sarcoma
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Tables from Unfolded Protein Response as a Therapeutic Target: 4-(Heptyloxy)phenol Induces Programmed Cell Death in Ewing Sarcoma
Table S1, Table S2, Table S3, Table S4, Table S5, Table S6, Table S7, Table S8, Table S9, Table S10, Table S11, Table S12, Table S13, Table S14
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Tables from Unfolded Protein Response as a Therapeutic Target: 4-(Heptyloxy)phenol Induces Programmed Cell Death in Ewing Sarcoma
Table S1, Table S2, Table S3, Table S4, Table S5, Table S6, Table S7, Table S8, Table S9, Table S10, Table S11, Table S12, Table S13, Table S14